These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38647290)

  • 21. Dysbiosis of the intestinal fungal microbiota increases lung resident group 2 innate lymphoid cells and is associated with enhanced asthma severity in mice and humans.
    Kanj AN; Kottom TJ; Schaefbauer KJ; Choudhury M; Limper AH; Skalski JH
    Respir Res; 2023 May; 24(1):144. PubMed ID: 37259076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fungal Colonization and Infections-Interactions with Other Human Diseases.
    Mahalingam SS; Jayaraman S; Pandiyan P
    Pathogens; 2022 Feb; 11(2):. PubMed ID: 35215155
    [No Abstract]   [Full Text] [Related]  

  • 23.
    Marra A; Hanson MA; Kondo S; Erkosar B; Lemaitre B
    mBio; 2021 Aug; 12(4):e0082421. PubMed ID: 34253067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteria-derived short-chain fatty acids as potential regulators of fungal commensalism and pathogenesis.
    McCrory C; Lenardon M; Traven A
    Trends Microbiol; 2024 May; ():. PubMed ID: 38729839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crossing Kingdoms: How the Mycobiota and Fungal-Bacterial Interactions Impact Host Health and Disease.
    Santus W; Devlin JR; Behnsen J
    Infect Immun; 2021 Mar; 89(4):. PubMed ID: 33526565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unveiling the hidden players: exploring the role of gut mycobiome in cancer development and treatment dynamics.
    Li L; Huang X; Chen H
    Gut Microbes; 2024; 16(1):2328868. PubMed ID: 38485702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal immune responses to fungi and the implications for inflammatory bowel disease.
    Limon JJ; Kershaw KM; Underhill DM
    Curr Opin Gastroenterol; 2018 Nov; 34(6):398-403. PubMed ID: 30299290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunity to Commensal Fungi: Detente and Disease.
    Wheeler ML; Limon JJ; Underhill DM
    Annu Rev Pathol; 2017 Jan; 12():359-385. PubMed ID: 28068483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From intestinal colonization to systemic infections:
    Sprague JL; Kasper L; Hube B
    Gut Microbes; 2022; 14(1):2154548. PubMed ID: 36503341
    [No Abstract]   [Full Text] [Related]  

  • 30. Phagocytes from Mice Lacking the Sts Phosphatases Have an Enhanced Antifungal Response to Candida albicans.
    Frank D; Naseem S; Russo GL; Li C; Parashar K; Konopka JB; Carpino N
    mBio; 2018 Jul; 9(4):. PubMed ID: 30018105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut mycobiome dysbiosis after sepsis and trauma.
    Park G; Munley JA; Kelly LS; Kannan KB; Mankowski RT; Sharma A; Upchurch G; Casadesus G; Chakrabarty P; Wallet SM; Maile R; Bible LE; Wang B; Moldawer LL; Mohr AM; Efron PA; Nagpal R
    Crit Care; 2024 Jan; 28(1):18. PubMed ID: 38212826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Intestinal Fungi and Viruses on Immune Responses and Inflammatory Bowel Diseases.
    Iliev ID; Cadwell K
    Gastroenterology; 2021 Mar; 160(4):1050-1066. PubMed ID: 33347881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fungi form interkingdom microbial communities in the primordial human gut that develop with gestational age.
    Willis KA; Purvis JH; Myers ED; Aziz MM; Karabayir I; Gomes CK; Peters BM; Akbilgic O; Talati AJ; Pierre JF
    FASEB J; 2019 Nov; 33(11):12825-12837. PubMed ID: 31480903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease.
    Yadav A; Yadav R; Sharma V; Dutta U
    Indian J Gastroenterol; 2024 Feb; 43(1):112-128. PubMed ID: 38409485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commensal fungi in intestinal health and disease.
    Ost KS; Round JL
    Nat Rev Gastroenterol Hepatol; 2023 Nov; 20(11):723-734. PubMed ID: 37479823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Manipulation of Host Diet To Reduce Gastrointestinal Colonization by the Opportunistic Pathogen Candida albicans.
    Gunsalus KT; Tornberg-Belanger SN; Matthan NR; Lichtenstein AH; Kumamoto CA
    mSphere; 2016; 1(1):. PubMed ID: 27303684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The human gut mycobiome and the specific role of Candida albicans: where do we stand, as clinicians?
    Musumeci S; Coen M; Leidi A; Schrenzel J
    Clin Microbiol Infect; 2022 Jan; 28(1):58-63. PubMed ID: 34363944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions among the mycobiome, bacteriome, inflammation, and diet in people living with HIV.
    Gosalbes MJ; Jimenéz-Hernandéz N; Moreno E; Artacho A; Pons X; Ruíz-Pérez S; Navia B; Estrada V; Manzano M; Talavera-Rodriguez A; Madrid N; Vallejo A; Luna L; Pérez-Molina JA; Moreno S; Serrano-Villar S
    Gut Microbes; 2022; 14(1):2089002. PubMed ID: 35748016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal immune responses to commensal and pathogenic protozoa.
    Sardinha-Silva A; Alves-Ferreira EVC; Grigg ME
    Front Immunol; 2022; 13():963723. PubMed ID: 36211380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly.
    Zhang F; Aschenbrenner D; Yoo JY; Zuo T
    Lancet Microbe; 2022 Dec; 3(12):e969-e983. PubMed ID: 36182668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.